The global Spinal Cord Stimulator market garnered revenue around USD XX Billion in 2019 and projected to reach USD 2 Billion in 2027, with at a compound annual growth rate of 9% throughout the estimate period from 2020 to 2027.
Spinal cord stimulator (SCS) is a type of implantable neuromodulation device. The device is used to send electric signals to the pain areas of the spinal cord for the treatment of certain pain conditions. SCS is also known as a dorsal column stimulator (DCS) or a pain pacemaker. Increasing demand for minimally invasive procedures, a rise in the number of patients suffering from failed back surgery syndrome, a growing number of patients suffering from chronic & neuropathic pain and rising prevalence of degenerative disc disease (DDD) are the factors that are expected to drive the market growth. As per recent studies, spinal cord stimulation can be used to treat a variety of diseases that result in chronic pain. Treated diagnoses include complex regional pain syndrome type I (45%) and type II (4%), failed back surgery syndrome (FBSS) (33%), visceral pain (5%), neuropathy (10%), and peripheral vascular disease (3%).
Currently, there are very few medical device companies in the market that are into the manufacturing of spinal cord stimulator devices. This is expected to create lucrative opportunities for other players in the industry to enter the spinal cord stimulator market.
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Spinal Cord Stimulator market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Spinal Cord Stimulator market growth.
The global Spinal Cord Stimulator market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Boston Scientific Corporation (US)
Abbott (US)
Nevro Corp. (US)
Medtronic (Ireland)
Stimwave LLC (US)
Nuvectra (US)
Beijing PINS Medical Co., Ltd (China)
Cirtec (US)
Synapse Biomedical Inc. (US)
NeuroSigma, Inc. (US)
Others
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
Information by Technology Type
Conventional Implantable Pulse Generator
Rechargeable Implantable Pulse Generator
Radiofrequency Stimulator
Application
Failed Back Surgery Syndrome
Complex Regional Pain Syndrome
Arachnoiditis
Sciatica
Degenerative Disc Disease
Others
End-User
Hospitals & Clinics
Ambulatory Surgical Centers and others
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization